Literature DB >> 31515103

Pure Autonomic Failure.

Elizabeth A Coon1, Wolfgang Singer2, Phillip A Low2.   

Abstract

Pure autonomic failure (PAF) is a neurodegenerative disorder of the autonomic nervous system clinically characterized by orthostatic hypotension. The disorder has also been known as Bradbury-Eggleston syndrome, named for the authors of the 1925 seminal description. Patients typically present in midlife or later with orthostatic hypotension or syncope. Autonomic failure may also manifest as genitourinary, bowel, and thermoregulatory dysfunction. With widespread involvement, patients may present to a variety of different specialties and require multidisciplinary treatment approaches. Pathologically, PAF is characterized by predominantly peripheral deposition of α-synuclein. However, patients with PAF may progress into other synucleinopathies with central nervous system involvement.
Copyright © 2019 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31515103      PMCID: PMC6826339          DOI: 10.1016/j.mayocp.2019.03.009

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  74 in total

1.  2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Authors:  Fred M Kusumoto; Mark H Schoenfeld; Coletta Barrett; James R Edgerton; Kenneth A Ellenbogen; Michael R Gold; Nora F Goldschlager; Robert M Hamilton; José A Joglar; Robert J Kim; Richard Lee; Joseph E Marine; Christopher J McLeod; Keith R Oken; Kristen K Patton; Cara N Pellegrini; Kimberly A Selzman; Annemarie Thompson; Paul D Varosy
Journal:  Heart Rhythm       Date:  2018-11-06       Impact factor: 6.343

2.  Renal impairment of pure autonomic failure.

Authors:  Emily M Garland; Alfredo Gamboa; Luis Okamoto; Satish R Raj; Bonnie K Black; Thomas L Davis; Italo Biaggioni; David Robertson
Journal:  Hypertension       Date:  2009-09-08       Impact factor: 10.190

3.  Pure autonomic failure without alpha-synuclein pathology: an evolving understanding of a heterogeneous disease.

Authors:  Elizabeth A Coon; Phillip A Low
Journal:  Clin Auton Res       Date:  2017-02-24       Impact factor: 4.435

4.  The potent pressor effect of phenylpropanolamine in patients with autonomic impairment.

Authors:  I Biaggioni; J Onrot; C K Stewart; D Robertson
Journal:  JAMA       Date:  1987-07-10       Impact factor: 56.272

5.  Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder.

Authors:  B F Boeve; M H Silber; T J Ferman; S C Lin; E E Benarroch; A M Schmeichel; J E Ahlskog; R J Caselli; S Jacobson; M Sabbagh; C Adler; B Woodruff; T G Beach; A Iranzo; E Gelpi; J Santamaria; E Tolosa; C Singer; D C Mash; C Luca; I Arnulf; C Duyckaerts; C H Schenck; M W Mahowald; Y Dauvilliers; N R Graff-Radford; Z K Wszolek; J E Parisi; B Dugger; M E Murray; D W Dickson
Journal:  Sleep Med       Date:  2013-03-07       Impact factor: 3.492

6.  The hypertension of autonomic failure and its treatment.

Authors:  J Shannon; J Jordan; F Costa; R M Robertson; I Biaggioni
Journal:  Hypertension       Date:  1997-11       Impact factor: 10.190

7.  Physical manoeuvres that reduce postural hypotension in autonomic failure.

Authors:  W Wieling; J J van Lieshout; A M van Leeuwen
Journal:  Clin Auton Res       Date:  1993-02       Impact factor: 4.435

8.  Pyridostigmine treatment trial in neurogenic orthostatic hypotension.

Authors:  Wolfgang Singer; Paola Sandroni; Tonette L Opfer-Gehrking; Guillermo A Suarez; Caroline M Klein; Stacy Hines; Peter C O'Brien; Jeffrey Slezak; Phillip A Low
Journal:  Arch Neurol       Date:  2006-02-13

9.  Cardiac Organ Damage and Arterial Stiffness in Autonomic Failure: Comparison With Essential Hypertension.

Authors:  Valeria Milazzo; Simona Maule; Cristina Di Stefano; Francesco Tosello; Silvia Totaro; Franco Veglio; Alberto Milan
Journal:  Hypertension       Date:  2015-10-12       Impact factor: 10.190

10.  Prospective evaluation of clinical characteristics of orthostatic hypotension.

Authors:  P A Low; T L Opfer-Gehrking; B R McPhee; R D Fealey; E E Benarroch; C L Willner; G A Suarez; C J Proper; J A Felten; C A Huck
Journal:  Mayo Clin Proc       Date:  1995-07       Impact factor: 7.616

View more
  18 in total

1.  Neurogenic Orthostatic Hypotension. Lessons From Synucleinopathies.

Authors:  Juan Francisco Idiaquez; Juan Idiaquez; Juan Carlos Casar; Italo Biaggioni
Journal:  Am J Hypertens       Date:  2021-03-11       Impact factor: 2.689

Review 2.  Genetics of synucleins in neurodegenerative diseases.

Authors:  José Brás; Elizabeth Gibbons; Rita Guerreiro
Journal:  Acta Neuropathol       Date:  2020-08-01       Impact factor: 17.088

Review 3.  Recent advances in establishing fluid biomarkers for the diagnosis and differentiation of alpha-synucleinopathies - a mini review.

Authors:  Wolfgang Singer
Journal:  Clin Auton Res       Date:  2022-07-27       Impact factor: 5.625

4.  Alpha-synuclein Immunization Strategies for Synucleinopathies in Clinical Studies: A Biological Perspective.

Authors:  Luisa Knecht; Jonas Folke; Richard Dodel; J Alexander Ross; Alexandra Albus
Journal:  Neurotherapeutics       Date:  2022-09-09       Impact factor: 6.088

5.  Movement disorder society criteria for the diagnosis of multiple system atrophy-what's new?

Authors:  Guillaume Lamotte; Horacio Kaufmann
Journal:  Clin Auton Res       Date:  2022-05-28       Impact factor: 5.625

Review 6.  Conformational strains of pathogenic amyloid proteins in neurodegenerative diseases.

Authors:  Dan Li; Cong Liu
Journal:  Nat Rev Neurosci       Date:  2022-05-30       Impact factor: 38.755

7.  Cerebrospinal fluid fistula in a patient with chronic constipation related to an autonomic dysfunction and revealed by bacterial meningitis - A case report.

Authors:  Hilal Abboud; Hanane Kharbouch; Yasser Arkha; Mohamed Choukri
Journal:  Surg Neurol Int       Date:  2020-07-18

8.  Alpha-Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic Failure.

Authors:  Wolfgang Singer; Ann M Schmeichel; Mohammad Shahnawaz; James D Schmelzer; David M Sletten; Tonette L Gehrking; Jade A Gehrking; Anita D Olson; Mariana D Suarez; Pinaki P Misra; Claudio Soto; Phillip A Low
Journal:  Ann Neurol       Date:  2021-04-30       Impact factor: 11.274

9.  Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies.

Authors:  Marcello Rossi; Niccolò Candelise; Simone Baiardi; Sabina Capellari; Giulia Giannini; Christina D Orrù; Elena Antelmi; Angela Mammana; Andrew G Hughson; Giovanna Calandra-Buonaura; Anna Ladogana; Giuseppe Plazzi; Pietro Cortelli; Byron Caughey; Piero Parchi
Journal:  Acta Neuropathol       Date:  2020-04-27       Impact factor: 17.088

Review 10.  The Role of Glial Mitochondria in α-Synuclein Toxicity.

Authors:  Yu-Mi Jeon; Younghwi Kwon; Myungjin Jo; Shinrye Lee; Seyeon Kim; Hyung-Jun Kim
Journal:  Front Cell Dev Biol       Date:  2020-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.